CHANGES IN ELF SCORE DURING TREATMENT WITH PEGYLATED INTERFERON AND SILYMARIN ARE ASSOCIATED WITH PROGRESSION OF HISTOLOGICAL LIVER DISEASE IN NON-RESPONDER PATIENTS WITH HEPATITIS C

被引：0
|
作者：
Tanwar, S. [1 ]
Ellis, E. [2 ]
Parkes, J. [2 ]
Herold, C. [3 ]
Rosenberg, W. [1 ]
机构：
[1] UCL, Ctr Hepatol, London, England
[2] Univ Southampton, Southampton, Hants, England
[3] Univ Erlangen Nurnberg, Erlangen, Germany
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)60127-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
125
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [1] CHANGES IN ELF SCORE DURING TREATMENT WITH PEGYLATED INTERFERON AND SILYMARIN ARE ASSOCIATED WITH PROGRESSION OF HISTOLOGICAL LIVER DISEASE IN NON-RESPONDER PATIENTS WITH CHRONIC HEPATITIS C
    Tanwar, S.
    Ellis, E.
    Parkes, J.
    Herold, C.
    Rosenberg, W.
    GUT, 2011, 60
  • [2] Changes in ELF Score During Treatment With Pegylated Interferon and Silymarin Are Associated With Progression of Histological Liver Disease in Non-Responder Patients With Chronic Hepatitis C
    Tanwar, Sudeep
    Ellis, Elizabeth L.
    Parkes, Julie
    Herold, Christoph
    Rosenberg, William M.
    GASTROENTEROLOGY, 2011, 140 (05) : S979 - S979
  • [3] Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C
    Fontana, Robert J.
    Dienstag, Jules L.
    Bonkovsky, Herbert L.
    Sterling, Richard K.
    Naishadham, Deepa
    Goodman, Zachary D.
    Lok, Anna S. F.
    Wright, Elizabeth C.
    Su, Grace L.
    GUT, 2010, 59 (10) : 1401 - 1409
  • [4] Treatment of interferon non-responder patients with chronic hepatitis C in Asia
    Nishioka, M.
    CHRONIC HEPATITIS: METABOLIC, CHOLESTATIC, VIRAL AND AUTOIMMUNE, 2007, 157 : 110 - 118
  • [5] Neutralizing antibodies to interferon alpha in a chronic hepatitis C patient non-responder to pegylated interferon
    Santantonio, Teresa
    Milella, Michele
    Antonelli, Guido
    Scagnolari, Carolina
    JOURNAL OF HEPATOLOGY, 2006, 45 (05) : 759 - 761
  • [6] Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen
    Biselli, M
    Andreone, P
    Gramenzi, A
    Lorenzini, S
    Loggi, E
    Bonvicini, F
    Cursaro, C
    Bernardi, M
    DIGESTIVE AND LIVER DISEASE, 2006, 38 (01) : 27 - 32
  • [7] Cyclic and periodic interferon treatment for chronic hepatitis C in non-responder to standard interferon treatment.
    Kishida, Y
    Naito, M
    Katayama, K
    Kashiwagi, T
    Hayashi, N
    Sasai, T
    Kinoshita, M
    HEPATOLOGY, 1998, 28 (04) : 699A - 699A
  • [8] New treatment strategies in non-responder patients with chronic hepatitis C
    Schalm, SW
    Brouwer, JT
    Bekkering, FC
    van Rossum, TGJ
    JOURNAL OF HEPATOLOGY, 1999, 31 : 184 - 188
  • [9] EFFECTS OF CASCADE FILTRATION IN COMBINATION WITH INTERFERON AND RIBAVIRIN IN THE TREATMENT OF NON-RESPONDER CHRONIC HEPATITIS C PATIENTS
    Ramunni, A.
    Brescia, P.
    Burzo, M.
    Verno, L.
    Rendina, M.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2010, 33 (07): : 436 - 436
  • [10] Consensus interferon for earlier non-responder or relapser patients with chronic hepatitis C.
    Karasu, Z
    Gurakar, A
    Jazzar, A
    Emmett, C
    Hulagu, S
    Wright, H
    HEPATOLOGY, 1999, 30 (04) : 629A - 629A
12345